Dr. Ross Camidge explains the treatment options for ALK-positive lung cancer. ALK is an important biomarker that can impact lung cancer treatment options. Talk to your doctor about comprehensive biomarker testing. Visit Lung.org/alk for more information. Support for this educational program provided by Amgen, AstraZeneca, Blueprint Medicines, Bristol Myers Squibb, Genentech, Lilly Oncology, Merck, Novartis and Pfizer.
WATCH VIDEO
American Lung Association
Authors: Dr. Ross Camidge